National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G ↓	Ingredients	Dosage	Form	Price
N05AH03	OLANZAPINE ARROW	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	1,385,502 L.L
N05AH03	OLANZAPINE ARROW	G	Olanzapine - 7.5mg	7.5mg	Tablet	822,432 L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 100mg/20ml	5mg/ml	Injectable concentrated solution	8,471,583 L.L
L01XA03	OXALIPLATIN MEDAC	G	Oxaliplatin - 100mg	100mg	Injectable powder for solution	7,841,801 L.L
L01XA03	OXALIPLATINE VIATRIS 5MG/ML	G	Oxaliplatin - 100mg	100mg	Injectable powder for solution	6,976,204 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	6,197,802 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	5,915,595 L.L
B05BC01	OSMITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	579,064 L.L
L01XA03	OXALIPLATIN EBEWE	G	Oxaliplatin - 50mg/10ml	50mg/10ml	Injectable concentrated solution	3,405,297 L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 50mg/10ml	5mg/ml	Injectable concentrated solution	3,450,988 L.L
L01XA03	OXALIPLATIN MEDAC	G	Oxaliplatin - 50mg	50mg	Injectable powder for solution	3,440,237 L.L
L01XA03	OXALIPLATINE VIATRIS 5MG/ML	G	Oxaliplatin - 50mg	50mg	Injectable powder for solution	4,428,565 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,956,454 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,957,797 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder	2,957,797 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 10mg	10mg	Tablet	966,287 L.L
C10AA05	ORVASTA	G	Atorvastatin - 10mg	10mg	Tablet, film coated	834,526 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 750mg	750mg	Tablet, film coated	499,372 L.L
M04AA03	OXUBAT 120	G	Febuxostat - 120mg	120mg	Tablet, film coated	1,549,002 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	223,078 L.L
M04AA03	OXUBAT 80	G	Febuxostat - 80mg	80mg	Tablet, film coated	1,549,002 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 1g	1,000mg	Tablet, film coated	683,273 L.L
A02BC01	OMEDAR	G	Omeprazole - 20mg	20mg	Tablet, enteric coated	18,087,352 L.L
A02BC01	OMEPRAL	G	Omeprazole - 20mg	20mg	Capsule, delayed release	213,735 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	415,951 L.L
A02BC01	OMEPRAZOLE PHARMADEX	G	Omeprazole - 20mg	20mg	Capsule	15,757,784 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	550,336 L.L
A02BC01	OMEZOL BENTA	G	Omeprazole - 20mg	20mg	Capsule	317,403 L.L
M05BA04	OREK	G	Alendronate - 70mg	70mg	Tablet, coated	2,404,838 L.L
M05BA04	OSTEOMED	G	Alendronic acid (sodium alendronate) - 70mg	70mg	Tablet, scored	950,929 L.L

...